EQUA HEALTH Institute for Regenerative Medicine, with the national stem cell authority Peng Xiang and national immune cell therapy pioneer Xia Jianchuan Xia as its chief scientific officers, has established a professional R&D and application team. The team has been focusing on stem cell and immune cell cutting-edge basic research, tissue engineering research, and regenerative medicine transformation application research. With cutting-edge technology, extremely stringent attitudes and standards, the Institute has established the core values of "safety, technology, and quality", and strived to innovate continuously to provide source of power for life and health, and has become a leader of comprehensive customized cell solutions
Treat and prevent cardiovascular diseases, neurodegenerative diseases, diabetes, sexual dysfunction, bone diseases, cancer and other diseases to improve the quality of life
Promote cell repair and regeneration, restore the physiological functions of tissues and organs, repair sub-health and chronic diseases, and improve immunity
The essence of human aging is cell aging and reduction. Customize brand new cells, replace and repair body senescent cells, reduce age and freeze age, and regenerate the body
laboratories that meet the international pharmaceutical production quality management standards and standards
Rigorous zero error quality testing
Comply with international AABB, FACT, ISCT standards
Each step is traceable
From the collection source to the preparation process, 48 quality assessments that exceed the standard and comprehensive three-dimensional quality control testing
Screen 8000 types of pathogenic microorganisms for cell donors, much higher than the test of 7 kinds of virus required by domestic standard
Ensure the activity and purity of each cell.The stand of cells is clinical, activity＞99.99%
Friend Links
微信公众号
